Intrinsiqs

Is Solventum Corporation overvalued?

Solventum Corporation (SOLV) looks overvalued — trading about 28% above its fair value.

Overvalued
Current price $89.50 Fair value $64.08
Price
$89.50
Fair value
$64.08
Current P/E
14.3
Normal P/E
10.3
Market cap
$15.50B
Dividend yield
0.0%
Return on equity
29.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SOLV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated